SINGER JACK W

CIK 00012042641 companySEATTLE, WA

SEC Profile

Transactions

Companies

Filings

CIK

0001204264

Recent Transactions

49 trades

Sale
CTI BIOPHARMA CORP
Common Stock
2015-12-18$1.17/sh−1,904→ 1,319,946 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-12-18$1.19/sh−400→ 1,306,850 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-12-18$1.18/sh−10,696→ 1,307,250 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-12-18$1.18/sh−2,000→ 1,317,946 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-09-30$1.45/sh−5,115→ 1,371,735 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-09-30$1.46/sh−19,034→ 1,351,850 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-09-30$1.46/sh−100→ 1,370,884 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-09-30$1.45/sh−751→ 1,370,984 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-09-29$1.40/sh−15,083→ 1,423,867 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-09-29$1.41/sh−28,254→ 1,386,350 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-09-29$1.42/sh−250→ 1,386,100 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-09-29$1.39/sh−7,300→ 1,438,950 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-09-29$1.43/sh−3,156→ 1,376,850 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-09-29$1.38/sh−5,600→ 1,446,250 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-09-29$1.41/sh−9,263→ 1,414,604 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-09-29$1.42/sh−6,094→ 1,380,006 total
Sale
CTI BIOPHARMA CORP
Common Stock
2012-06-29$0.60/sh−1,100→ 2,503,604 total
Sale
CTI BIOPHARMA CORP
Common Stock
2012-06-29$0.60/sh−200→ 2,516,074 total
Sale
CTI BIOPHARMA CORP
Common Stock
2012-06-29$0.60/sh−26,070→ 2,477,534 total
Sale
CTI BIOPHARMA CORP
Common Stock
2012-06-29$0.59/sh−11,260→ 2,516,274 total
Sale
CTI BIOPHARMA CORP
Common Stock
2012-06-29$0.60/sh−11,370→ 2,504,704 total
Award
CTI BIOPHARMA CORP
Common Stock
2012-06-27+37,161→ 2,527,534 total
Award
CTI BIOPHARMA CORP
Common Stock
2012-01-03+1,639,414→ 2,497,966 total
Award
CTI BIOPHARMA CORP
Common Stock
2012-01-03+1,639,414→ 2,497,966 total
Disposition to Issuer
CTI BIOPHARMA CORP
Common Stock
2011-12-31−673,636→ 858,552 total
Disposition to Issuer
CTI BIOPHARMA CORP
Common Stock
2011-12-31−673,636→ 858,552 total
Disposition to Issuer
CTI BIOPHARMA CORP
Common Stock
2009-12-31−6,048→ 2,140,579 total
Disposition to Issuer
CTI BIOPHARMA CORP
Common Stock
2009-12-31−6,048→ 2,140,579 total
Sale
CTI BIOPHARMA CORP
Common Stock
2009-01-05$0.13/sh−1,520→ 101,445 total
Award
CTI BIOPHARMA CORP
Incentive Stock Option (right to buy)
2007-01-18+70,000→ 70,000 total
Disposition to Issuer
CTI BIOPHARMA CORP
Common Stock
2007-01-01−100,000→ 339,465 total
Sale
CTI BIOPHARMA CORP
Common Stock
2006-12-11$1.92/sh−1,600→ 455,490 total
Sale
CTI BIOPHARMA CORP
Common Stock
2006-12-11$1.92/sh−1,600→ 455,490 total
Sale
CTI BIOPHARMA CORP
Common Stock
2005-07-01$2.70/sh−3,200→ 441,716 total
Sale
CTI BIOPHARMA CORP
Common Stock
2005-07-01$2.70/sh−3,200→ 441,716 total
Sale
CTI BIOPHARMA CORP
Common Stock
2005-01-03$8.11/sh−400→ 343,676 total
Sale
CTI BIOPHARMA CORP
Common Stock
2005-01-03$8.10/sh−1,200→ 344,076 total
Sale
CTI BIOPHARMA CORP
Common Stock
2005-01-03$8.01/sh−1,600→ 345,276 total
Sale
CTI BIOPHARMA CORP
Common Stock
2005-01-03$8.11/sh−400→ 343,676 total
Sale
CTI BIOPHARMA CORP
Common Stock
2005-01-03$8.01/sh−1,600→ 345,276 total
Sale
CTI BIOPHARMA CORP
Common Stock
2005-01-03$8.10/sh−1,200→ 344,076 total
Exercise/Conversion
CTI BIOPHARMA CORP
Incentive Stock Option (right to buy)
2004-01-05−5,000→ 34,531 total
Sale
CTI BIOPHARMA CORP
Common Stock
2004-01-05$10.00/sh−5,000→ 333,476 total
Exercise/Conversion
CTI BIOPHARMA CORP
Common Stock
2004-01-05$2.91/sh+5,000→ 0 total
Exercise/Conversion
CTI BIOPHARMA CORP
Incentive Stock Option (right to buy)
2004-01-05−5,000→ 34,531 total
Sale
CTI BIOPHARMA CORP
Common Stock
2004-01-05$10.00/sh−5,000→ 333,476 total
Exercise/Conversion
CTI BIOPHARMA CORP
Common Stock
2004-01-05$2.91/sh+5,000→ 0 total
Award
CTI BIOPHARMA CORP
Common Stock
2004-01-01+40,000→ 333,476 total
Award
CTI BIOPHARMA CORP
Common Stock
2004-01-01+40,000→ 333,476 total

Companies

CTI BIOPHARMA CORP
Director, EVP, Chief Medical Officer

Recent Filings

Address

501 ELLIOTT AVENUE WEST SUITE 400

SEATTLE, WA, 98119

View on SEC.gov